KLOR-CON M15 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Klor-con M15, and what generic alternatives are available?
Klor-con M15 is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in KLOR-CON M15 is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klor-con M15
A generic version of KLOR-CON M15 was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KLOR-CON M15?
- What are the global sales for KLOR-CON M15?
- What is Average Wholesale Price for KLOR-CON M15?
Summary for KLOR-CON M15
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 314 |
| Patent Applications: | 2,331 |
| DailyMed Link: | KLOR-CON M15 at DailyMed |
Pharmacology for KLOR-CON M15
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for KLOR-CON M15
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | KLOR-CON M15 | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 074726-003 | Jun 6, 2003 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
